Dough-strengthening mechanism
Glucose oxidase generates hydrogen peroxide from glucose and dissolved oxygen in the dough. That hydrogen peroxide oxidises the free thiol (-SH) groups on gluten proteins into disulphide (-S-S-) bonds. The resulting cross-linked gluten network is stronger and more elastic, improving loaf volume and crumb uniformity. This is well characterised in food science literature.
Glucose oxidase from Aspergillus niger added to wheat dough at typical bakery concentrations increased loaf volume and improved crumb texture by promoting gluten cross-linking via hydrogen peroxide generation.
LabFood Chemistry / multiple baking-science reviews
Safety evaluations by EFSA
Because food enzymes have their own EU regulatory pathway (Regulation 1332/2008), EFSA's Food Enzyme Panel evaluates each glucose oxidase preparation individually, by production organism and strain. Scientific opinions published in 2018 and 2023 assessed glucose oxidase from specific genetically modified strains and found no safety concern at the estimated dietary exposure from baking use. These opinions feed into the European Commission's formal authorisation process; the authorisation decision itself is issued by the Commission under Regulation 1331/2008. The enzyme is fully inactivated by baking heat, so residual active enzyme in food is not a practical concern. The 2023 opinion for the Saccharomyces cerevisiae strain LALL-GO noted that the risk of allergic reactions could not be excluded due to sequence homology with an almond allergen, though dietary exposure through finished baked goods is considered low risk because the enzyme is destroyed by baking.
EFSA's Food Enzyme Panel evaluated glucose oxidase produced by a genetically modified Aspergillus oryzae strain (NZYM-KP, produced by Novozymes A/S) and found no safety concern at use levels up to 1,000 GODU/kg flour in bread and baked goods. The opinion was adopted 6 June 2018 and published in the EFSA Journal.
2018Regulatory reviewEFSA Journal, Food Enzyme Panel; PMC7009544
EFSA's Food Enzyme Panel evaluated glucose oxidase from genetically modified Saccharomyces cerevisiae (strain LALL-GO, produced by Lallemand Inc.), adopted 12 September 2023. The Panel found no safety concern at dietary exposure levels but noted that the risk of allergic reactions cannot be excluded due to sequence homology with an almond allergen.
2023Regulatory reviewEFSA Journal, Food Enzyme Panel; PMC10556996
Allergenicity from production organisms
Some glucose oxidase preparations are produced using Aspergillus fungi or genetically modified organisms. EFSA evaluations routinely check whether the production organism introduces allergenic proteins into the preparation. For commercially sold enzyme concentrates the production strain is removed and the preparation is purified, so allergenic carry-over is not considered a real-world concern for the general population. The 2023 EFSA opinion for the LALL-GO (Saccharomyces cerevisiae) strain found sequence homology with an almond allergen, but the risk via dietary exposure to finished baked goods is considered low because the enzyme is inactivated by baking. Individuals with rare occupational hypersensitivity to Aspergillus enzymes (bakers' asthma) may react, but this is an occupational rather than a dietary route.
Occupational exposure to fungal enzyme powders, including glucose oxidase, is associated with sensitisation and bakers' asthma in bakery workers; dietary exposure from finished baked goods does not carry this risk because the enzyme is inactivated by baking.
ObservationalOccupational and Environmental Medicine; general food-enzyme allergenicity literature
